| Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis K Gulyás, Á Horváth, E Végh, A Pusztai, Á Szentpétery, Z Pethö, A Váncsa, ... Clinical rheumatology 39, 167-175, 2020 | 71 | 2020 |
| Effects of targeted therapies on the bone in arthritides Á Szentpétery, Á Horváth, K Gulyás, Z Pethö, HP Bhattoa, S Szántó, ... Autoimmunity Reviews 16 (3), 313-320, 2017 | 62 | 2017 |
| Anti-mutated citrullinated vimentin (anti-MCV) and anti-65 kDa heat shock protein (anti-hsp65): new biomarkers in ankylosing spondylitis N Bodnár, Z Szekanecz, Z Prohászka, Á Kemény-Beke, ... Joint Bone Spine 79 (1), 63-66, 2012 | 36 | 2012 |
| Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis K Gulyas, N Bodnar, Z Nagy, S Szamosi, A Horvath, A Vancsa, E Vegh, ... The European Journal of Health Economics 15, 93-100, 2014 | 32 | 2014 |
| Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis A Hamar, Z Szekanecz, A Pusztai, M Czókolyová, E Végh, Z Pethő, ... Osteoporosis International, 1-9, 2021 | 31 | 2021 |
| Vitamin D status in men with psoriatic arthritis: a case-control study Z Petho, E Kulcsar-Jakab, E Kalina, A Balogh, A Pusztai, K Gulyas, ... Osteoporosis International 26, 1965-1970, 2015 | 26 | 2015 |
| Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls B Juhasz, K Gulyas, A Horvath, Z Pethő, HP Bhattoa, A Vancsa, ... Osteoporosis International 28, 1271-1277, 2017 | 21 | 2017 |
| Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: a metabolomic approach B Soós, A Hamar, A Pusztai, M Czókolyová, E Végh, S Szamosi, Z Pethő, ... Frontiers in medicine 9, 1011734, 2022 | 10* | 2022 |
| OP0272 Effects of Anti-TNF Therapy on Markers of Bone Homeostasis in Rheumatoid Arthritis and Ankylosing Spondylitis Ά Horváth, A Pusztai, K Gulyás, A Váncsa, E Végh, N Bodnár, P Csomor, ... Annals of the rheumatic diseases 74 (Suppl 2), 175-175, 2015 | 4 | 2015 |
| Laser-induced plasma spectroscopy (LIPS): use of a geological tool in assessing bone mineral content L Andrássy, I Gomez, Á Horváth, K Gulyás, Z Pethö, B Juhász, HP Bhattoa, ... Lasers in Medical Science 33, 1225-1236, 2018 | 3 | 2018 |
| FRI0547 Osteoporosis and bone metabolism in systemic sclerosis Ά Horváth, K Gulyás, HP Bhattoa, G Szücs, Z Szekanecz, S Szamosi Annals of the Rheumatic Diseases 76 (Suppl 2), 697-697, 2017 | 2 | 2017 |
| A4. 3 Effects of anti-TNF therapy on markers of bone homeostasis in rheumatoid arthritis and ankylosing spondylitis Á Horváth, A Pusztai, K Gulyás, A Váncsa, E Végh, N Bodnár, P Csomor, ... Annals of the Rheumatic Diseases 74 (Suppl 1), A37-A37, 2015 | 2 | 2015 |
| Application of Laser-based geological techniques to bone research: Calcium oxide distribution analyses of animal bones L Andrássy, G Maros, IJ Kovács, Á Horváth, K Gulyás, É Bertalan, ... Orvosi Hetilap 155 (45), 1783-1793, 2014 | 2 | 2014 |
| P133 Clinical and immunological effects of tofacitinib therapy in rheumatoid arthritis A Hamar, A Pusztai, E Végh, Á Horváth, K Gulyás, S Szamosi, Z Pethő, ... Annals of the Rheumatic Diseases 78 (Suppl 1), A59-A60, 2019 | 1 | 2019 |
| AB0551 Long-term effects of etanercept treatment on vascular function and lipid parameters in ankylosing spondylitis N Bodnár, G Kerekes, E Végh, K Gulyás, F Balázs, L Pogácsás, I Pál, ... Annals of the Rheumatic Diseases 72 (Suppl 3), A958-A958, 2013 | 1 | 2013 |
| THU0399 Effects of 12-Month Etanercept Therapy on Disease Activity, Bone Turnover Markers and Peripheral QCT Bone Mineral Density in Patients with Ankylosing Spondylitis S Szántó, K Gulyás, N Bodnár, Á Horváth, Z Pethö, B Juhász, E Végh, ... Annals of the Rheumatic Diseases 72 (Suppl 3), A300-A300, 2013 | 1 | 2013 |
| AB0606 Effects of 12-month etanercept or certolizumab pegol therapy on disease activity, bone turnover markers and peripheral qct bone mineral density in patients with … A Váncsa, HP Bhattoa, E Végh, K Gulyás, Á Horváth, Z Pethö, B Juhász, ... Annals of the Rheumatic Diseases 72 (Suppl 3), A975-A975, 2013 | 1 | 2013 |
| Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: a metabolomic approach B Soós, A Hamar, A Pusztai, M Czokolyova, E Vegh, S Szamosi, Z Petho, ... ANNALS OF THE RHEUMATIC DISEASES 80, 421-422, 2021 | | 2021 |
| POS0043 PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY IN THE ASSESSMENT OF BONE MINERAL DENSITY IN ANTI-TNF-TREATED RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS B Juhász, K Gulyás, Á Horváth, E Végh, A Pusztai, A Szentpetery, Z Pethö, ... Annals of the Rheumatic Diseases 80 (Suppl 1), 226-227, 2021 | | 2021 |
| POS0390 SIMULTANEOUS ASSESSMENT OF JOINT AND VASCULAR INFLAMMATION BY PET-CT IN TOFACITINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS: A PROSPECTIVE STUDY A Hamar, Z Hascsi, A Pusztai, M Czókolyová, E Végh, Z Pethö, K Gulyás, ... Annals of the Rheumatic Diseases 80 (Suppl 1), 425-425, 2021 | | 2021 |
